Investment Insights for Profits with Purpose

Colgate-Palmolive may not grab headlines, but its fundamentals are strengthening. With projected earnings growth of 47.6% and pricing power intact, the setup is improving. Its focus on efficiency and sustainability supports both margins and brand strength. A quiet compounder with credible upside.

Your portfolio may be generating returns—but do you know what’s driving them? Investing with values isn’t about sacrificing performance. It’s about understanding what your money supports—and gaining the clarity to align both.

Deckers is a standout example of responsible growth investing in action. With strong brand power, high profitability, and double-digit growth, it continues to compound value. Sustainability and employee satisfaction reinforce its competitive edge. At current valuation levels, the market may be underestimating its long-term potential.

What if investing for positive impact didn’t just align with your values — but actually boosted your returns? New research from Oxford and Schroders shows that impact-aligned equity portfolios can deliver superior risk-adjusted performance, proving that doing good and doing well don’t have to be trade-offs.

Boston Scientific is quietly becoming one of the most compelling growth stories in medical technology. Its devices treat life threatening diseases while delivering powerful financial performance. With strong revenue growth, expanding margins, and major innovation in cardiac care, the company combines profit with purpose. After a recent sell off, the stock may offer attractive long term upside.

Impact and ESG are often confused—but they measure fundamentally different things, and mixing them can lead investors astray. This article breaks down why ESG focuses on financial risk while impact measures real-world outcomes, and why that distinction matters if you want your portfolio to truly align with your values and long-term returns. Discover how Ziggma uses transparent, institutional-grade impact data to cut through greenwashing and show exactly what your capital is supporting.

Ralph Lauren is blending brand power with improving profitability and credible sustainability progress. Earnings are accelerating, margins are expanding, and climate and labor metrics are moving in the right direction. With a Ziggma Score of 79 and Impact Score of 71, RL stands out in global apparel. Here is why the stock could continue compounding for patient investors.

Impact investing is not ESG investing. While ESG focuses on risks to a company’s financial value, impact investing measures how companies contribute to real-world outcomes for people and the planet. Ziggma’s Impact Score is powered by ACA Ethos, one of the industry’s most rigorous impact data engines, analyzing ~600 metrics across 80+ impact topics and monitoring global controversies daily. The result is a transparent, outcome-focused view of how portfolios, companies, and funds truly align with a more sustainable and equitable future.

Intuitive Surgical pairs double digit earnings growth with rising margins and a dominant position in robotic surgery. With a Ziggma Score of 98 and strong financial health, the return case is compelling. The company also scores highly on employee satisfaction and gender equity. ISRG stands out as a rare blend of growth, quality, and responsible corporate practice.

Amalgamated Financial is one of the few publicly listed US banks that is also a certified B Corp. It combines double-digit earnings growth with a valuation near 10 times earnings, a rare mix in banking. Beyond returns, AMAL actively finances climate solutions, affordable housing, and community development. This is a bank where profit and purpose reinforce each other.

Every investment leaves a footprint. Just as everyday consumption choices shape the world around us, investing in public equities and funds quietly but powerfully influences which companies grow, which business models scale, and which behaviors are rewarded. Whether intentional or not, your portfolio helps shape the economy and understanding that impact is the first step toward investing with clarity and purpose.

Host Hotels & Resorts pairs a nearly 5% dividend yield with ownership of some of the best hotels in the US. Its recovery in profits and cash flow highlights the power of premium real estate. On impact, Host aligns to a 1.5°C climate pathway while improving waste recycling and labor practices. A steady income play with real assets and real progress.

Impact investing goes beyond avoiding harm—it’s about intentionally allocating capital to companies that deliver measurable positive outcomes while still targeting competitive returns. As nearly 90% of global investors now express interest in sustainable and impact-oriented strategies, understanding how impact differs from ESG, and how it’s created through public markets, has never mattered more. This article breaks it all down and shows how investors can turn good intentions into disciplined, data-driven decisions that align portfolios with real-world progress.

Latin America’s fastest-growing platform is turning scale into cash and impact. Can MercadoLibre keep compounding returns while further improving its sustainability profile?

The data’s getting hard to ignore — companies solving real-world problems are also delivering real-world profits. A joint study by Schroders and Oxford Saïd Business School finds up to 9% annual alpha through impact investing. This post breaks down what the numbers are really saying about making money and making impact.

Microsoft is printing cash at a scale few companies can match, with profit margins above 55 percent and revenue still growing at double-digit rates. At the same time, it is running nearly entirely on renewable energy and targeting carbon negativity by 2030. The market may still be underestimating how much pricing power and upside remain. This is what a true long-term Good Stock looks like.

NVIDIA sits at the center of the global AI revolution, delivering exceptional growth and profitability at an unprecedented scale. Its GPUs power everything from data centers to climate modeling and medical research. While valuation is demanding, earnings growth and a deep competitive moat support continued upside. NVIDIA proves that cutting-edge innovation and positive real-world impact can go hand in hand.

Eli Lilly is redefining what scale and impact look like in modern healthcare. Its leadership in weight loss and metabolic disease is driving accelerating growth and exceptional profitability. At the same time, these therapies are improving lives and reducing long term health risks worldwide. For investors, Lilly offers a rare mix of quality, growth, and meaningful impact.